Skip to content
Film Television Auditions – Lifestyle
Author:
Sutro Biopharma, Inc.
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
October 21, 2026
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
October 12, 2026
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
September 29, 2026
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
August 12, 2026
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
May 14, 2026